Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
PE Ratio: Discounted Valuation
Trending lower, below historical average, strong compound growth.
Left:
||||
Price-to-earnings ratio
Latest
-193.61
↓ 1824% below average
Average (9y)
-10.06
Historical baseline
Range
High:141.54
Low:-193.61
CAGR
+15.2%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | -193.61 | -768.3% |
| 2023 | 28.97 | +30.1% |
| 2022 | 22.26 | -7.9% |
| 2021 | 24.16 | +6.7% |
| 2020 | 22.65 | -52.6% |
| 2019 | 47.77 | +137.7% |
| 2018 | 20.10 | -85.8% |
| 2017 | 141.54 | +188.4% |
| 2016 | -160.15 | -195.0% |
| 2015 | -54.30 | - |